Therapy Areas: Allergy
9 September 2019 - The US Food and Drug Administration (FDA) has granted Ridgeback Biotherapeutics LP, a biotechnology company, Breakthrough Therapy designation for its mAb114, an experimental Ebola t...
30 August 2019 - - US-based pharmaceutical company VenatoRx Pharmaceuticals has initiated enrollment in its Phase 3 trial of cefepime/VNRX-5133 in patients with complicated urinary tract infections (c...
22 August 2019 - - US-based VenatoRx Pharmaceuticals has added pharmaceutical industry veterans, Jennifer Ellis, Dr. Paul McGovern and Lauren P. Tornetta to its development team, the company said.
21 August 2019 - United States-based Signant Health has added Anthony Todd Everhart, MD, FACP to the Signant Health Science and Medicine Team as clinical vice president, Internal Medicine, it was repo...
15 August 2019 - Research company RTI International reported on Wednesday the receipt of approval from the US Food and Drug Administration (FDA) for the new drug pretomanid for treating Extensively Dr...
12 August 2019 - - US-based plasma-derived therapeutic products maker Kedrion Biopharma has initiated the CARES10 (Clinical Assessment of phaRmacokinetics, Efficacy, Safety of a 10...
Related Headlines